Warnex Inc.
TSX : WNX

Warnex Inc.

November 13, 2009 08:35 ET

Warnex Appoints a New Director

LAVAL, QUEBEC--(Marketwire - Nov. 13, 2009) - Warnex Inc. (TSX:WNX) is pleased to announce that The Honourable Baljit S. Chadha has joined the Board of Directors of Warnex.

Baljit Singh Chadha, PC, has significant expertise in international trade, marketing and strategic planning. He is president of Balcorp Limited, an international trade and marketing firm, which he founded in 1976 and built into a successful company with about $100 million in sales and offices in Montreal, New Delhi and Mumbai. Balcorp has diversified interests in agri-food products, forestry products, minerals and services.

Mr. Chadha is also a well known philanthropist and a leader of the Indian community in Canada. He has been a key player in a number of international trade missions and treaty development processes. He also sits on the Board of Governors of Concordia University, has advised the Office of the Mayor of Montreal on Indo-Canadian affairs and has served on the advisory board of the Indo-Canada Chamber of Commerce. In 2003, he was appointed by Prime Minister Jean Chretien to the Security Intelligence Review Committee as well as the Queen's Privy Council for Canada.

About Warnex

Warnex (www.warnex.ca) is a life sciences company devoted to protecting public health by providing laboratory services to the pharmaceutical and healthcare sectors. Warnex Analytical Services provides pharmaceutical and biotechnology companies with a variety of quality control services, including chemistry, chromatography, microbiology, method development and validation, and stability studies. Warnex Bioanalytical Services specializes in bioequivalence and bioavailability studies for clinical trials. Warnex Medical Laboratories provides specialized testing for the healthcare industry as well as pharmaceutical and central laboratory services. Warnex PRO-DNA Services offers DNA identification tests for paternity, maternity and other family relationships, as well as for immigration and forensic testing purposes. Warnex has three facilities located in Laval and Blainville, Quebec, and Thunder Bay, Ontario.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS

Certain statements contained in this news release are forward-looking and are subject to numerous risks and uncertainties, known and unknown. For information identifying known risks and uncertainties, relating to financial resources, government regulations, laboratory facilities, suppliers, employees, key customers and business partners, foreign currency risk, credit risk, liquidity risk, volatility of share price, and other important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the heading Risks and Uncertainties in Warnex's most recent Management's Discussion and Analysis, which can be found at www.sedar.com. Consequently, actual results may differ materially from the anticipated results expressed in these forward-looking statements.

Contact Information